As of 2024-12-15, the Relative Valuation of Trillium Therapeutics Inc (TRIL.TO) is (29.46) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 23.33 CAD, the upside of Trillium Therapeutics Inc based on Relative Valuation is -226.3%.
The range of the Relative Valuation is (23.57) - (35.35) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 33.3x - 49.9x | 41.6x |
| Forward P/E multiples | 33.3x - 49.9x | 41.6x |
| Fair Price | (23.57) - (35.35) | (29.46) |
| Upside | -201.0% - -251.5% | -226.3% |
| Date | P/E |